Azodyl in Renal Failure Trial (ART) ART is the first placebo-controlled clinical trial examining the efficacy of Azodyl ®in reducing azotemia and uremia in cats with chronic renal failure. This trial is being conducted by Dr. Mark Rishniw and Paul Pion at the Veterinary Information Network (VIN) and has been largely funded by the VIN Foundation.

 

To read more about this study visit http://www.vin.com/ART/